Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients

Acta Reumatologica Portuguesa

Volumn 34, Issue 3, 2009, Pages 498-502

  Wallin, Liz ^a   Quintilio, Wagner ^b   Locatelli, Felipe ^a   Cassel, Albino ^a   Silva, Marilia Barreto ^a   Skare, Thelma L ^a  

^a Hospital Universitario   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

Immunization; Influenza; Systemic lupus erythematosus; Vaccination

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; INFLUENZA; MALE; MIDDLE AGED; ORTHOMYXOVIRUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, VIRAL; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; ORTHOMYXOVIRIDAE; YOUNG ADULT;

EID: 73349090627     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bouza E, Moya JGL, Munoz P. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect Dis Clin N Am 2001; 15: 335-361.
2. Alarcón GS. Infections in Systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Infect Dis Clin N Am 2006; 20: 849-875.
3. O'Neill SG, Isenberg DA. Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety. Lupus 2006; 15:778-73.
4. Mercado U. Why have rheumatologists been reluctant to vaccinate patients with systemic lupus erythematosus? J Rheumatol 2006; 33: 1469-1471.
5. Stojanovich L. Influenza vaccination of patients with systemic lupus eryhtematosus and rheumatoid arthritis. Clin Dev Immunol 2006; 13:373-375.
6. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-" vaccinosis': a dangerous liaison? J Autoimmun 2000; 14:1-10.
7. Abu-Shakra M, Press J, Varsano N, et al. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 2002; 29:2555-2557.
8. Mercado U. Antibody response to influenza immunization in patients with systemic lupus erythematosus. J Rheumatol 2003; 19: 2295-2296.
9. Abu-Shakra M, Press J, Sukenik S, Buskila D. Influenza virus vaccination of patients with SLE: effects on generation of autoantibodies. Clin Rheumatol 2002; 369-372.
10. Kanakoudi-Tsakalidou F, Trachana M, Pratsidou-Gertsi P, Tsitsami S, Kyriasopoulou-Dalaina V. Influenza vaccination in children with chronic rheumatic disease and long term immunossupressive therapy. Clin Exp Rheumatol 2001; 19: 589-594.
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
12. Bombardier C, Gladman DD, Urowits MB, Caron D, Chan CH. Derivations of SLEDAI. A disease activity index for lupus patients. Arthritis & Rheum 1992; 35:630-640.
13. WHO Manual on Animal Influenza Diagnosis and Surveillance, WHO/CDS/CSR/NCS/2002.5 Rev. 1 Available at: http://www.who.int/csr/resources/publications/influenza/whocdscsrncs2002 5rev.pdf
14. Holvast A, Huckriede A, Wilschut J, et al. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 2006; 65:913-918.
15. Fomin I, Caspi D, Varsano N, et al. Vaccination against influenza in rheumatoid arthritis: The effect of disease modifying drugs, including TNFα blockers. Ann Rheum Dis 2006;65:191-194.